Pilocarpine

VUITY™ (pilocarpine HCI ophthalmic solution) 1.25% is approved by FDA to treat Presbyopia (Age-Related Blurry Near Vision)

NORTH CHICAGO, USA., Oct. 29, 2021 Allergan, an AbbVie (NYSE: ABBV) company, announced the U.S. Food and Drug Administration (FDA) approval of VUITY™ (pilocarpine HCl ophthalmic solution) 1.25% for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. VUITY is the first and only FDA-approved eye drop to treat this…